Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Tycoon Group Announces 2022 Interim Results 2022-08-30 22:47
Waterdrop receives the NBD "2022 Green Practice Pioneering Projects" 2022-08-30 22:00
Fosun Pharma Announces 2022 Interim Results 2022-08-30 20:28
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Six Months Ended June 30, 2022 2022-08-30 18:00
Kintor Announces 2022 Interim Results and Recent Business Update 2022-08-30 00:19
Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences 2022-08-29 21:00
NEXT-GENERATION EGFR TKI H002 FROM REDCLOUD BIO COMPLETES FIRST DOSE IN NON-SMALL CELL LUNG CANCER 2022-08-29 19:30
Porton Advanced and Royaltech Announce Strategic Collaboration to Accelerate the Development of Bacterial Drugs and mRNA Drugs 2022-08-29 12:23
First Vietnam's natural mineral water brand provides perfect alkalinity pH = 9.0 from the premium unique mineral source of Danh Thanh 2022-08-29 10:00
Sanyou Biopharmaceuticals and KangaBio established strategic collaboration to accelerate antibody drug development and innovation 2022-08-28 08:00
ProSomnus® Sleep Technologies Announces Signing of Definitive Agreements for $30 Million of Convertible Notes 2022-08-27 04:30
Ascentage Pharma Announces 2022 Interim Results 2022-08-27 00:47
Waterdrop Releases User Family Insurance Report 2022-08-26 22:00
First approval of Cadonilimab (PD-1/CTLA-4 bispecific) published in Drugs, a peer-reviewed medical journal 2022-08-26 20:00
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy in Europe 2022-08-25 19:25
Tigermed Reports 2022 Interim Result with Strong Financial Growth 2022-08-25 19:05
111, Inc. Announces Second Quarter 2022 Unaudited Financial Results 2022-08-25 14:18
Alpha Biopharma Announces Completion of its EVEREST Phase II/III Clinical Study of Zorifertinib in Non-Small Cell Lung Cancer Patients with Central Nervous System Metastases 2022-08-25 10:00
Asieris Pharmaceuticals (688176.SH) Issued 2022 Semi-Annual Report: Accelerated Global Clinical Development and Progressive Implementation of Its Integrated Diagnosis-Treatment Commercialization Strategy 2022-08-25 00:46
CEO of Waterdrop Peng Shen was appointed as Vice-chairman of the Overseas Students and Chinese Committee of the Beijing Youth Federation 2022-08-24 22:10
1 141 142 143 144 145 812